Requests that the FDA issue a declaration permitting the submission of an Abbreviated New Drug Application for Gabapentin Capsules, 150 mg.
🏛 Food and Drug Administration (FDA)FDA-2026-P-5123
Documents
6
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Other· Jun 23, 2026No comment period